NRAS and melanoma: Similarly, Gutierrez-Prat et al. recently reported that depletion of DUSP4, another ERK1/2 negative regulator, reduces proliferation by driving “oncogene overdose” in BRAF- and NRAS-mutant melanoma cell lines47.